RESUMO
BACKGROUND AND AIM: Phytoestrogens are traditionally used for cardiovascular risks but direct effects on the ischemic heart remain unclear. Plants with phytoestrogens are used for reducing menopausic symptoms and they could also be cardioprotectives. Here we investigated whether maca (Lepidium meyenii) contains isoflavones and prevents cardiac stunning, in comparison to soy isoflavones. EXPERIMENTAL PROCEDURE: Both products were orally and daily administered to rats during 1 week before exposing isolated hearts to ischemia/reperfusion (I/R). Young male (YM), female (YF) and aged female (AgF) rats treated with maca (MACA, 1 g/kg/day) or soy isoflavones (ISOF, 100 mg/kg/day) were compared to acute daidzein (DAZ, 5 mg/kg i.p.) and non-treated rat groups. Isolated ventricles were perfused inside a calorimeter to simultaneously measure contractile and calorimetrical signals before and during I/R. RESULTS AND CONCLUSIONS: Maca has genistein and daidzein. MACA and ISOF improved the post-ischemic contractile recovery (PICR) and muscle economy (P/Ht) in YM and YF hearts, but not in AgF hearts. DAZ improved PICR and P/Ht more in YM than in YF. The mKATP channels blockade reduced both PICR and P/Ht in DAZ-treated YM hearts, without affecting them in ISOF or MACA-treated YM hearts. In MACA treated YF hearts, the simultaneous blockade of NOS and mKATP channels, or the mNCX blockade reduced cardioprotection. Results show that subacute oral treatment with maca or with soy isoflavones was strongly preventive of cardiac ischemic dysfunction, more than the acute administration of a pure isoflavone (daidzein, genistein). Maca induced synergistic and complex mechanisms which prevented mitochondrial calcium overload.
RESUMO
Background: The application of cryopreservation in human and animal reproductive medicine has stimulated several studies about the effects of low temperatures and freezing processes on cells and tissues, in order to develop efficient protocols for gamete and embryo preservation. Moreover, cryopreservation is a fundamental tool for the establishment of animal germplasm banks, allowing the preservation of genetic material from several species and breeds or for further study and/or recovery of desirable characteristics. For the success of cryopreservation, the addition of an intracellular cryoprotectant agent in the freezing solution is indispensable. However, issues related to intracellular cryoprotectant agents used, e.g., their metabolism and potential toxicity, must be examined carefully so we can choose the cryoprotectant most suitable for a specific structure. Review: In this regard, this review introduces several aspects of cryopreservation, such as basic principles and methods used (slow freezing and vitrification), describing the fundamental steps of cryoprotectant agents exposure, cooling, storage, thawing or warming and removal of the cryoprotectant agent. The addition of an intracellular cryoprotectant to the freezing solution is essential, but does not guarantee the success of the cryopreservation protocol, due to its toxic effect, which requires a perfect balance between cryoprotectant concentration, temperature and exposure time to the structure which will be cryopreserved. Some studies attribute the toxicity of these agents mainly to the secondary metabolites formed when the cell resumes its activi ty and gradually begins to metabolize the cryoprotectant agent.[...]
Assuntos
Crioprotetores/análise , Folículo Ovariano , Oócitos , CriopreservaçãoRESUMO
Background: The application of cryopreservation in human and animal reproductive medicine has stimulated several studies about the effects of low temperatures and freezing processes on cells and tissues, in order to develop efficient protocols for gamete and embryo preservation. Moreover, cryopreservation is a fundamental tool for the establishment of animal germplasm banks, allowing the preservation of genetic material from several species and breeds or for further study and/or recovery of desirable characteristics. For the success of cryopreservation, the addition of an intracellular cryoprotectant agent in the freezing solution is indispensable. However, issues related to intracellular cryoprotectant agents used, e.g., their metabolism and potential toxicity, must be examined carefully so we can choose the cryoprotectant most suitable for a specific structure. Review: In this regard, this review introduces several aspects of cryopreservation, such as basic principles and methods used (slow freezing and vitrification), describing the fundamental steps of cryoprotectant agents exposure, cooling, storage, thawing or warming and removal of the cryoprotectant agent. The addition of an intracellular cryoprotectant to the freezing solution is essential, but does not guarantee the success of the cryopreservation protocol, due to its toxic effect, which requires a perfect balance between cryoprotectant concentration, temperature and exposure time to the structure which will be cryopreserved. Some studies attribute the toxicity of these agents mainly to the secondary metabolites formed when the cell resumes its activi ty and gradually begins to metabolize the cryoprotectant agent.[...](AU)